Make your money go further for just 25p per day

AIM IHT

Coronavirus impact: 20 July - positive news from a respiratory drug

Synairgen

Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.


Synairgen: shares soar of positive Covid-19 test results

The share price of Synairgen (LON: SNG), the AIM quoted respiratory drug discovery company, soared over 350% as it announced positive results from its clinical trial of SNG001, its wholly-owned inhaled formulation of interferon beta, in hospitalised Covid-19 patients.

The trial results showed that SNG001 greatly reduced the number of hospitalised Covid-19 patients who progressed from ‘requiring oxygen’ to ‘requiring ventilation’. It also showed that patients who received…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login

Fundamental Asset Management
Buy any of our portfolios with our associates.
 

FIND OUT MORE

Previous article Next article

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world

REGISTER FREE

Become a Champion Investor for just £90 a year.
 
 

START FREE TRIAL

More on Gamma Communications PLC

Strong updates from some high-quality AIM companies

11/01/2021 · Company Insights

Several of AIM’s higher quality companies issued positive trading updates and in quick time after their…


Coronavirus impact: 8 Sept - fabulous results from this AIM blue chip and much more

08/09/2020 · Company Insights

There were a large number of announcements today, including fabulous results from a fast growing provider of…


More on MJ Hudson Group PLC

Coronavirus impact: 20 July - positive news from a respiratory drug

20/07/2020 · Company Insights

Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.


Coronavirus impact: 1 June - more positive news for a video gaming company

01/06/2020 · Company Insights

Video gaming continues to be in high demand, Dart sells its distribution business and a provider…


More on Pittards

Coronavirus impact: 30 Sept - some big pandemic winners and losers

30/09/2020 · Company Insights

Boohoo Group announced another set of fantastic results and, with a huge pile of cash at…


Coronavirus impact: 20 July - positive news from a respiratory drug

20/07/2020 · Company Insights

Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.


More on Synairgen

Coronavirus impact: 20 July - positive news from a respiratory drug

20/07/2020 · Company Insights

Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.


Coronavirus impact: 18 June - a big day of news from Covid-19 testers

18/06/2020 · Company Insights

Covid-19 test and vaccine developers were in the spotlight as they continue to make progress with…


More on Venture Life Group PLC

Bonkers Bargain updates and more

01/02/2021 · Company Insights

Bonkers Bargains covered in our update here appear to be doing all the right things and the…


​Venture Life: fund raise and Director selling is scandalous!

20/11/2020 · Company Insights

The shares have gone nowhere since IPO but Directors are bizarrely allowed to exercise options and…


More Company Insights

Stonking Small Caps: impressive growth here

26/02/2021

​Yet another cannabis company joins the London market

All things online steal the show